The store will not work correctly when cookies are disabled.
2,7-dihydroxy-4-methyl-5-(4-(naphthalen-2-yl)phenyl)cyclohepta-2,4,6-trien-1-one
ID: ALA4533691
PubChem CID: 124132306
Max Phase: Preclinical
Molecular Formula: C24H18O3
Molecular Weight: 354.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(O)c(=O)c(O)cc1-c1ccc(-c2ccc3ccccc3c2)cc1
Standard InChI: InChI=1S/C24H18O3/c1-15-12-22(25)24(27)23(26)14-21(15)18-9-6-17(7-10-18)20-11-8-16-4-2-3-5-19(16)13-20/h2-14H,1H3,(H2,25,26,27)
Standard InChI Key: ILBIRAPXPVPOMM-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
32.5869 -2.0043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3245 -1.6612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0588 -2.0239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3960 -2.8008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2355 -2.8204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9001 -3.4458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7182 -3.4516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3340 -0.8441 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.7018 -1.5195 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.9543 -1.4871 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.5393 -4.1790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0652 -4.1914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5972 -4.8598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9435 -5.5992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7586 -5.6691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2261 -4.9937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8772 -4.2571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1069 -6.4049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6388 -7.0762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9861 -7.8150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9180 -6.4717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2679 -7.2078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8027 -7.8816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1537 -8.6192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9696 -8.6843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4333 -8.0057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0797 -7.2708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 2 0
3 5 2 0
4 6 1 0
5 7 1 0
6 7 2 0
2 8 2 0
3 9 1 0
1 10 1 0
6 11 1 0
7 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
18 19 2 0
19 20 1 0
20 23 2 0
22 21 2 0
21 18 1 0
15 18 1 0
22 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 354.41 | Molecular Weight (Monoisotopic): 354.1256 | AlogP: 5.25 | #Rotatable Bonds: 2 |
Polar Surface Area: 57.53 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.03 | CX Basic pKa: ┄ | CX LogP: 5.24 | CX LogD: 5.24 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.52 | Np Likeness Score: 0.16 |
References
1. Berkowitz AJ, Franson AD, Gazquez Cassals A, Donald KA, Yu AJ, Garimallaprabhakaran AK, Morrison LA, Murelli RP.. (2019) Importance of lipophilicity for potent anti-herpes simplex virus-1 activity of α-hydroxytropolones., 10 (7): [PMID:31391890] [10.1039/C9MD00225A] |